Mexico Neurothrombectomy Devices Market Size & Outlook
Mexico neurothrombectomy devices market, 2018-2030 (US$M)
Related Markets
Mexico neurothrombectomy devices market highlights
- The Mexico neurothrombectomy devices market generated a revenue of USD 13.3 million in 2023 and is expected to reach USD 19.2 million by 2030.
- The Mexico market is expected to grow at a CAGR of 5.3% from 2024 to 2030.
- In terms of segment, clot retrievers was the largest revenue generating product in 2023.
- Aspiration/Suction Devices is the most lucrative product segment registering the fastest growth during the forecast period.
Neurothrombectomy devices market data book summary
| Market revenue in 2023 | USD 13.3 million |
| Market revenue in 2030 | USD 19.2 million |
| Growth rate | 5.3% (CAGR from 2023 to 2030) |
| Largest segment | Clot retrievers |
| Fastest growing segment | Aspiration/Suction Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clot Retrievers, Aspiration/Suction Devices, Vascular Snares |
| Key market players worldwide | Medtronic PLC, Acandis GmbH, Stryker Corp, Penumbra Inc, Phenox, Vesalio |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.9% of the global neurothrombectomy devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil neurothrombectomy devices market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 32.8 million by 2030.
Clot retrievers was the largest segment with a revenue share of 57.14% in 2023. Horizon Databook has segmented the Mexico neurothrombectomy devices market based on clot retrievers, aspiration/suction devices, vascular snares covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico neurothrombectomy devices market is anticipated to witness low growth over the forecast period. Decrease in healthcare expenditure by the government and lack of adequate healthcare facilities in the country are major factors restraining the market growth.
According to the report published by countryeconomy.com in 2018, the healthcare expenditure was around 2.81% of the GDP in 2018 whereas in 2016 it was 2.86%. Such decrease in healthcare expenditure often restricts many new and key players to enter the Mexican market.
Moreover, lack of skilled professionals and less knowledge regarding treatment of acute ischemic stroke are factors expected to impede the market growth. A majority of the patients prefer treatment outside the country due to shortage of hospitals and clinics in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurothrombectomy Devices Market Scope
Neurothrombectomy Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico neurothrombectomy devices market size, by product, 2018-2030 (US$M)
Mexico Neurothrombectomy Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
